EBD Group is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy
Share/Follow Us
Share this:
Follow this event:
Subscribe to our newsletters:

Partnerships in Cell and Gene Therapies Press Releases

partnering360:Insight Latest headlines from partnering360:Insight

February 14, 2018 Clinical trials specifically for biotechs: A distinct solution born from the recent integration of Covance and Chiltern Nimble biotechs have different needs than large pharmaceutical organizations. That’s why a new biotech-specific clinical trial solution was launched in January under Chiltern, a Covance company brand, the result of the recent Covance and Chiltern integration.  more ►

February 6, 2018 China: The pace of innovation is measured in ‘dog years’ China’s biotech climate is improving rapidly, with CFDA regulations revamped to speed development, and investors eager to fund companies. Nearly USD 40 billion was raised for life sciences in 2017. more ►

January 12, 2018 Health is the new wealth: Investing in digital innovation 2017 broke all funding records for digital health, proving the point that “health is the new wealth,” as one panelist said at the Digital Medicine & Medtech Showcase in San Francisco January 10, 2018. more ►

January 12, 2018 Data: Rocket fuel for healthcare Big data combined with AI technologies has the potential to unlock knowledge and fuel innovation. That requires a data strategy based upon the right type and density of data. If the data set is too small or too thin, the strategy is likely to fail, according to panelists speaking at Biotech Showcase in San Francisco January 9. more ►

January 9, 2018 Is biotech at a tipping point? Is there such a thing? Every few years, commentators say the biotech industry is at a tipping point…that it’s poised for the next inflection. Ron Cohen, president and CEO, Acorda Therapeutics, Inc. and a panelist at Biotech Showcase’s luncheon plenary January 8 in San Francisco, says there’s no such thing as a tipping point. more ►

Arrow Up

Follow this event:
Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use